| Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012 | 3295 | 2012 |
| Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes DP Steensma, R Bejar, S Jaiswal, RC Lindsley, MA Sekeres, ... Blood, The Journal of the American Society of Hematology 126 (1), 9-16, 2015 | 1904 | 2015 |
| Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia EM Stein, CD DiNardo, DA Pollyea, AT Fathi, GJ Roboz, JK Altman, ... Blood, The Journal of the American Society of Hematology 130 (6), 722-731, 2017 | 1452 | 2017 |
| Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML CD DiNardo, EM Stein, S de Botton, GJ Roboz, JK Altman, AS Mims, ... New England Journal of Medicine 378 (25), 2386-2398, 2018 | 1347 | 2018 |
| Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ... Annals of Oncology 31 (6), 745-759, 2020 | 963 | 2020 |
| Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ... Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009 | 527 | 2009 |
| Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis H Makishima, V Visconte, H Sakaguchi, AM Jankowska, S Abu Kar, ... Blood, The Journal of the American Society of Hematology 119 (14), 3203-3210, 2012 | 480 | 2012 |
| Luspatercept in patients with lower-risk myelodysplastic syndromes P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ... New England Journal of Medicine 382 (2), 140-151, 2020 | 451 | 2020 |
| STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia A Jerez, MJ Clemente, H Makishima, H Koskela, F LeBlanc, K Peng Ng, ... Blood, The Journal of the American Society of Hematology 120 (15), 3048-3057, 2012 | 442 | 2012 |
| Inherited and somatic defects in DDX41 in myeloid neoplasms C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ... Cancer cell 27 (5), 658-670, 2015 | 436 | 2015 |
| Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 427 | 2017 |
| Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML LP Gondek, R Tiu, CL O'Keefe, MA Sekeres, KS Theil, JP Maciejewski Blood, The Journal of the American Society of Hematology 111 (3), 1534-1542, 2008 | 404 | 2008 |
| Acute myeloid leukemia RM Stone, MR O'Donnell, MA Sekeres ASH Education Program Book 2004 (1), 98-117, 2004 | 403 | 2004 |
| Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A AM Jankowska, H Makishima, RV Tiu, H Szpurka, Y Huang, F Traina, ... Blood, The Journal of the American Society of Hematology 118 (14), 3932-3941, 2011 | 368 | 2011 |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ... Leukemia 28 (1), 78-87, 2014 | 360 | 2014 |
| Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib EM Stein, CD DiNardo, AT Fathi, DA Pollyea, RM Stone, JK Altman, ... Blood, The Journal of the American Society of Hematology 133 (7), 676-687, 2019 | 352 | 2019 |
| Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes DA Sallman, AE DeZern, G Garcia-Manero, DP Steensma, GJ Roboz, ... Journal of clinical oncology 39 (14), 1584, 2021 | 347 | 2021 |
| 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in … AJ Dunbar, LP Gondek, CL O'Keefe, H Makishima, MS Rataul, H Szpurka, ... Cancer research 68 (24), 10349-10357, 2008 | 336 | 2008 |
| Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation T Yoshizato, Y Nannya, Y Atsuta, Y Shiozawa, Y Iijima-Yamashita, ... Blood, The Journal of the American Society of Hematology 129 (17), 2347-2358, 2017 | 305 | 2017 |
| Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys MA Sekeres, WM Schoonen, H Kantarjian, A List, J Fryzek, R Paquette, ... JNCI: Journal of the National Cancer Institute 100 (21), 1542-1551, 2008 | 294 | 2008 |
